183 related articles for article (PubMed ID: 34904011)
1. Improved Ocular Bioavailability of Moxifloxacin HCl using PLGA Nanoparticles: Fabrication, Characterization,
Khan FU; Nasir F; Iqbal Z; Neau S; Khan I; Hassan M; Iqbal M; Ullah A; Khan SI; Sakhi M
Iran J Pharm Res; 2021; 20(3):592-608. PubMed ID: 34904011
[TBL] [Abstract][Full Text] [Related]
2. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
Nanomedicine; 2010 Apr; 6(2):324-33. PubMed ID: 19857606
[TBL] [Abstract][Full Text] [Related]
3. Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections:
Elhabal SF; Ghaffar SA; Hager R; Elzohairy NA; Khalifa MM; Mohie PM; Gad RA; Omar NN; Elkomy MH; Khasawneh MA; Abdelaal N
Int J Pharm X; 2023 Dec; 5():100174. PubMed ID: 36908304
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity.
Kırımlıoğlu GY; Özer S; Büyükköroğlu G; Yazan Y
Comb Chem High Throughput Screen; 2021; 24(3):328-341. PubMed ID: 32342810
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of 2-HP-β-cyclodextrin-PLGA nanoparticle complexes for potential use as ocular drug delivery vehicles.
Li F; Wen Y; Zhang Y; Zheng K; Ban J; Xie Q; Wen Y; Liu Q; Chen F; Mo Z; Liu L; Chen Y; Lu Z
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4097-4108. PubMed ID: 31663388
[No Abstract] [Full Text] [Related]
6. Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections.
Nair AB; Shah J; Jacob S; Al-Dhubiab BE; Sreeharsha N; Morsy MA; Gupta S; Attimarad M; Shinu P; Venugopala KN
PLoS One; 2021; 16(3):e0248857. PubMed ID: 33739996
[TBL] [Abstract][Full Text] [Related]
7. Investigation of moxifloxacin loaded chitosan-dextran nanoparticles for topical instillation into eye: In-vitro and ex-vivo evaluation.
Kaskoos RA
Int J Pharm Investig; 2014 Oct; 4(4):164-73. PubMed ID: 25426437
[TBL] [Abstract][Full Text] [Related]
8. Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery.
Yousry C; Elkheshen SA; El-Laithy HM; Essam T; Fahmy RH
Eur J Pharm Sci; 2017 Mar; 100():142-154. PubMed ID: 28089661
[TBL] [Abstract][Full Text] [Related]
9. Oral delivery of topotecan in polymeric nanoparticles: Lymphatic distribution and pharmacokinetics.
Jeong SH; Jang JH; Lee YB
J Control Release; 2021 Jul; 335():86-102. PubMed ID: 34015399
[TBL] [Abstract][Full Text] [Related]
10. Preparation and In Vitro/Ex Vivo Evaluation of Moxifloxacin-Loaded PLGA Nanosuspensions for Ophthalmic Application.
Mudgil M; Pawar PK
Sci Pharm; 2013; 81(2):591-606. PubMed ID: 23833723
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles laden in situ gel for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Pharm Bioallied Sci; 2013 Apr; 5(2):162-5. PubMed ID: 23833523
[TBL] [Abstract][Full Text] [Related]
12. QbD-based Formulation Optimization and Characterization of Polymeric Nanoparticles of Cinacalcet Hydrochloride with Improved Biopharmaceutical Attributes.
Ghose D; Patra CN; Ravi Kumar BVV; Swain S; Jena BR; Choudhury P; Shree D
Turk J Pharm Sci; 2021 Sep; 18(4):452-464. PubMed ID: 34496552
[TBL] [Abstract][Full Text] [Related]
13. Nanoemulsion Based Vehicle for Effective Ocular Delivery of Moxifloxacin Using Experimental Design and Pharmacokinetic Study in Rabbits.
Shah J; Nair AB; Jacob S; Patel RK; Shah H; Shehata TM; Morsy MA
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31083593
[TBL] [Abstract][Full Text] [Related]
14. Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation.
Liu R; Wang S; Fang S; Wang J; Chen J; Huang X; He X; Liu C
Nanoscale Res Lett; 2016 Dec; 11(1):254. PubMed ID: 27188974
[TBL] [Abstract][Full Text] [Related]
15. An Improvement of the Efficacy of Moxifloxacin HCl for the Treatment of Bacterial Keratitis by the Formulation of Ocular Mucoadhesive Microspheres.
Dandagi PM; Belekar AM; Mastiholimath VS; Gadad AP; Sontake VW; Salian PS
Sci Pharm; 2013; 81(1):259-80. PubMed ID: 23641344
[TBL] [Abstract][Full Text] [Related]
16. Promising bioadhesive ofloxacin-loaded polymeric nanoparticles for the treatment of ocular inflammation: formulation and in vivo evaluation.
Salama AH; AbouSamra MM; Awad GEA; Mansy SS
Drug Deliv Transl Res; 2021 Oct; 11(5):1943-1957. PubMed ID: 33006742
[TBL] [Abstract][Full Text] [Related]
17. Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in-vitro, in-vivo evaluation.
Mahor A; Prajapati SK; Verma A; Gupta R; Iyer AK; Kesharwani P
J Colloid Interface Sci; 2016 Dec; 483():132-138. PubMed ID: 27552421
[TBL] [Abstract][Full Text] [Related]
18. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
Salama AH; Mahmoud AA; Kamel R
AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
[TBL] [Abstract][Full Text] [Related]
19. Improvement of Ocular Efficacy of Levofloxacin by Bioadhesive Chitosan Coated PLGA Nanoparticles: Box-behnken Design,
Ameeduzzafar ; Khan N; Alruwaili NK; Bukhari SNA; Alsuwayt B; Afzal M; Akhter S; Yasir M; Elmowafy M; Shalaby K; Ali A
Iran J Pharm Res; 2020; 19(1):292-311. PubMed ID: 32922488
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
